Title |
Prevalence and Risk of Polypharmacy among the Elderly in an Outpatient Setting
|
---|---|
Published in |
Drugs & Aging, August 2012
|
DOI | 10.2165/11584990-000000000-00000 |
Pubmed ID | |
Authors |
S. Lane Slabaugh, Vittorio Maio, Megan Templin, Safiya Abouzaid |
Abstract |
Polypharmacy, the simultaneous taking of many medications, has been well documented and is a topic of much concern for those looking to improve the quality of care for the elderly. Elderly patients often develop complicated and multifactorial health states that require extensive pharmacotherapy, leaving this population at risk for exposure to drug-drug interactions and other adverse events. Previous literature supports an association between an increase in the rate of adverse events as the number of drugs taken by a patient increases. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Finland | 1 | <1% |
Spain | 1 | <1% |
Unknown | 130 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 20 | 15% |
Student > Master | 20 | 15% |
Student > Bachelor | 12 | 9% |
Student > Postgraduate | 11 | 8% |
Other | 9 | 7% |
Other | 22 | 17% |
Unknown | 38 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 45 | 34% |
Pharmacology, Toxicology and Pharmaceutical Science | 22 | 17% |
Nursing and Health Professions | 7 | 5% |
Agricultural and Biological Sciences | 4 | 3% |
Social Sciences | 2 | 2% |
Other | 8 | 6% |
Unknown | 44 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2022.
All research outputs
#7,149,102
of 25,374,917 outputs
Outputs from Drugs & Aging
#498
of 1,293 outputs
Outputs of similar age
#52,098
of 187,867 outputs
Outputs of similar age from Drugs & Aging
#128
of 372 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 1,293 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,867 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 372 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.